Mouse MAU(Microalbuminuria) ELISA Kit
中文名称:小鼠尿微量白蛋白(MAU)酶联免疫吸附测定试剂盒
别称:
UMA、MAlb
Price:
Size:
96T
48T
96T*5
- 反应性: Mouse
- 检测范围: 0.16-10 ng/mL
- 灵敏度: 0.1 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠MAU抗体包被于酶标板上,实验时样品(或标准品)中的小鼠MAU会与包被抗体结合。后依次加入生物素化的抗小鼠MAU抗体和辣根过氧化物酶标记的亲和素,抗小鼠MAU抗体与结合在包被抗体上的小鼠MAU结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,MAU浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中MAU的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Mouse |
检测方法 | Colormetric |
检测范围 | 0.16-10 ng/mL |
灵敏度 | 0.1 ng/mL |
样本体积 | 100μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的小鼠MAU,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice
IF: 17.694 -
Metrnl alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy
IF: 9.337Journal:DIABETES -
BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease
IF: 8.469 -
Abelmoschus Manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non-obese diabetes mice
IF: 6.575Journal:Microbial Biotechnology -
Bisdemethoxycurcumin Attenuated Renal Injury via Activation of Keap1/Nrf2 Pathway in High-Fat Diet-Fed Mice
IF: 6.208 -
Prediction of cellular targets in diabetic kidney diseases with single-cell transcriptomic analysis of db/db mouse kidneys
IF: 5.908 -
miR-124-3p improves mitochondrial function of renal tubular epithelial cells in db/db mice
IF: 5.834Journal:FASEB JOURNAL -
Interaction between Plasma Metabolomics and Intestinal Microbiome in db/db Mouse, an Animal Model for Study of Type 2 Diabetes and Diabetic Kidney Disease
IF: 5.581 -
Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose–treated HK-2 cells
IF: 4.545Journal:BIOMEDICINE & PHARMACOTHERAPY -
Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism
IF: 4.162